You have searched for "Bottle"
Showing 51-60 of 4126
NEW DELHI (Reuters) - Leaders of the United States, India, Australia and Japan agreed to pool financing, manufacturing and distribution capacity to send 1 billion coronavirus vaccines across Asia by the end of 2022, India's foreign secretary said on Friday.
ALOR GAJAH: A 29-year-old man doused his friend with petrol and set him alight - all over the suspected theft of a smartphone.
(Reuters) - The European Medicines Agency said on Wednesday there was no evidence so far linking AstraZeneca's COVID-19 vaccine to illnesses in two people who received it in Austria, one of whom died 10 days after being inoculated.
WASHINGTON (Reuters) - A first ever leaders' meeting of the Quad group of countries on Friday plans to announce financing agreements to support an increase in manufacturing capacity for coronavirus vaccines in India, a senior U.S administration official told Reuters.
LONDON (Reuters) - A representative of the EU's delegation in Britain has been summoned by London after European Council President Charles Michel said the country has an outright ban on exports of COVID-19 shots, The Sun newspaper reported.
KUALA LUMPUR: Malaysia’s total procurement of 32 million doses of the Pfizer-BioNTech Covid-19 vaccine will be enough to cover half its population, says Science, Technology and Innovation Minister Khairy Jamaluddin.
BANGKOK (Reuters) - Thai Prime Minister Prayuth Chan-ocha left reporters stunned and amused on Tuesday when he interrupted his own news conference to spray them with hand sanitiser in a bid to dodge tough questions.
BRUSSELS (Reuters) - Johnson & Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its COVID-19 vaccine to the bloc in the second quarter of the year, an EU official told Reuters.
WASHINGTON (Reuters) - White House spokeswoman Jen Psaki said on Monday that President Joe Biden's administration was monitoring efforts tied to Russia's intelligence services aimed at undermining the Moderna Inc and Pfizer Inc coronavirus vaccines.
GENEVA (Reuters) - Waiving intellectual property rights will not be enough to resolve COVID-19 vaccine access issues, the developers of the Oxford/Astrazeneca and the Pfizer/BioNTech vaccines said on Monday, ahead of a meeting on the topic at the World Trade Organization this week.